ExodusPoint Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-60,193
| Closed | -$896K | – | 1790 |
|
|
2024
Q4 | $896K | Buy |
+60,193
| New | +$896K | 0.01% | 891 |
|
|
2024
Q3 | – | Sell |
-58,951
| Closed | -$898K | – | 1877 |
|
|
2024
Q2 | $898K | Buy |
+58,951
| New | +$898K | 0.01% | 936 |
|
|
2024
Q1 | – | Sell |
-182,865
| Closed | -$3.49M | – | 1759 |
|
|
2023
Q4 | $3.49M | Sell |
182,865
-70,275
| -28% | -$1.34M | 0.02% | 389 |
|
|
2023
Q3 | $4.54M | Sell |
253,140
-183,330
| -42% | -$3.29M | 0.04% | 367 |
|
|
2023
Q2 | $8.87M | Buy |
436,470
+9,258
| +2% | +$188K | 0.07% | 243 |
|
|
2023
Q1 | $7.79M | Buy |
427,212
+393,201
| +1,156% | +$7.17M | 0.06% | 289 |
|
|
2022
Q4 | $703K | Buy |
34,011
+11,116
| +49% | +$230K | 0.01% | 1037 |
|
|
2022
Q3 | $599K | Sell |
22,895
-46,492
| -67% | -$1.22M | 0.01% | 1268 |
|
|
2022
Q2 | $1.76M | Buy |
69,387
+39,600
| +133% | +$1M | 0.02% | 795 |
|
|
2022
Q1 | $940K | Buy |
+29,787
| New | +$940K | 0.01% | 1140 |
|
|
2021
Q1 | – | Sell |
-8,390
| Closed | -$218K | – | 2449 |
|
|
2020
Q4 | $218K | Buy |
+8,390
| New | +$218K | ﹤0.01% | 1617 |
|
|
2020
Q3 | – | Sell |
-41,698
| Closed | -$1.03M | – | 2083 |
|
|
2020
Q2 | $1.03M | Buy |
+41,698
| New | +$1.03M | 0.03% | 708 |
|
|
2019
Q3 | – | Sell |
-12,784
| Closed | -$102K | – | 1551 |
|
|
2019
Q2 | $102K | Buy |
+12,784
| New | +$102K | ﹤0.01% | 993 |
|